MOHW mulls NHI drug approval. system based on positive list

Published: 2004-03-15 06:58:00

Updated: 2004-03-15 06:58:00

MOHW said that almost all of drugs registered to KFDA were automatically listed to the NHI reimbursement book, for which, MOHW thought it to raise problems that should be trimmed in view of efficient NHI drug controls, and therefore announced "Assigned study projects for health medical technology...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK